Siemens, Medtronic close acquisitions:
This article was originally published in Clinica
Executive Summary
The first week of November saw the conclusion of two significant acquisitions by medtech powerhouses Siemens Medical Solutions and Medtronic. Siemens closed its $7bn acquisition of US lab diagnostics company Dade Behring on Tuesday. The addition of Dade's clinical lab portfolio, which netted sales of $1.7bn in 2006, gives Siemens a major leg up the IVD ladder, making it the industry's largest player (excluding diabetes testing products). Medtronic completed its $4.2bn purchase of Kyphon, the balloon kyphoplasty and spinal products specialist, on Friday (November 2). The acquisition is expected to bulk up Medtronic's existing spinal business so that it can compete better in one of the fastest-growing segments in the orthopaedics industry. Both Siemens and Medtronic had entered into their respective agreements in July.
You may also be interested in...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.